Allergy and Immunology, Allergy · Walnut Creek, CA
NPI
1215920673
Since 2005
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
370 N Wiget Ln Ste 210
Walnut Creek, CA, 94598
Phone (925) 935-6252
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
70,779 services
Medicare patients, 2024
335
Average age 74
Drug cost, 2024
$6.4M
1,745 prescriptions
Company payments, 2025
$250K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua S Jacobs was code J2356 (injection, tezepelumab-ekko, 1 mg), 41,160 times for 26 patients. In total Joshua S Jacobs billed 70,779 services in 54 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 41,160 | 26 | $14.21 | $585K |
| J2357 Injection, omalizumab, 5 mg | Office | 8,025 | 17 | $29.83 | $239K |
| J0517 Injection, benralizumab, 1 mg | Office | 2,460 | 16 | $130.96 | $322K |
| 95004 Test - Miscellaneous | Office | 1,590 | 43 | $3.58 | $5,691 |
| 95165 Treatment - Miscellaneous | Office | 896 | 57 | $12.01 | $11K |
| 95117 Treatment - Miscellaneous | Office | 637 | 46 | $12.22 | $7,787 |
| 96372 Injection Administration | Office | 566 | 63 | $13.88 | $7,854 |
| 99214 Office E&M - Established | Office | 529 | 258 | $112.50 | $60K |
| 95012 Pulmonary | Office | 231 | 144 | $19.95 | $4,609 |
| 96160 E&M - Miscellaneous | Office | 228 | 137 | $3.19 | $727 |
| 95115 Treatment - Miscellaneous | Office | 215 | 20 | $9.94 | $2,137 |
| 94010 Pulmonary Function Testing | Office | 186 | 118 | $27.41 | $5,099 |
| 95024 Test - Miscellaneous | Office | 117 | 26 | $8.53 | $998 |
| 96365 Intravenous Infusion, Hydration | Office | 86 | 12 | $66.49 | $5,718 |
| 99204 Office E&M - New | Office | 54 | 54 | $147.57 | $7,969 |
By year: 2022 $1.1M for 43,048 services; 2023 $1.3M for 56,231 services; 2024 $1.5M for 70,779 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87635 COVID Specific | 43 | 39 | $50.53 | $2,173 |
Medicare prescription drug claims, 2024
In 2024, the drug Joshua S Jacobs prescribed most often to Medicare patients was Montelukast Sodium, with 317 prescriptions and refills. In total Joshua S Jacobs wrote 1,745 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 317 | 770 | 86 | $3,232 |
| Azelastine Hcl Generic | 142 | 298 | 73 | $4,397 |
| Breo Ellipta Fluticasone/Vilanterol | 97 | 123 | 17 | $47K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 68 | 82 | 46 | $2,229 |
| Dupixent Syringe Dupilumab | 67 | 77 | Under 11 | $273K |
| Ipratropium Bromide Generic | 61 | 115 | 29 | $2,045 |
| Epinephrine Generic | 53 | 59 | 46 | $9,080 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 52 | 104 | 17 | $65K |
| Qvar Redihaler Beclomethasone Dipropionate | 51 | 65 | 15 | $17K |
| Famotidine Generic | 46 | 72 | 16 | $439 |
| Haegarda C1 Esterase Inhibitor | 42 | 42 | Under 11 | $1.9M |
| Symbicort Budesonide/Formoterol Fumarate | 41 | 55 | Under 11 | $13K |
| Prednisone Generic | 40 | 66 | 14 | $124 |
| Fluticasone Propionate Generic | 38 | 85 | 17 | $629 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 35 | 41 | Under 11 | $26K |
Brand drugs: - claims; generic drugs: 1,008 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua S Jacobs $250K ($250K in general payments such as food, travel and fees) from 28 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $108K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 126 | $108K |
| CSL Behring CSL.AX | 49 | $64K |
| Ionis Pharmaceuticals, Inc. IONS | 30 | $14K |
| Genzyme Corporation SNY | 23 | $13K |
| Novartis Pharmaceuticals Corporation NVS | 17 | $13K |
| BioCryst Pharmaceuticals, Inc. BCRX | 8 | $7,092 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $6,049 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $4,734 |
| Grifols USA, LLC | 8 | $3,688 |
| GlaxoSmithKline, LLC. GSK | 21 | $2,882 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.